Bachem
Update in progressBANB.SW (Swiss)
- Company RatingNeutralCompany RatingCombines sentiment and sustainability signals into an overall assessment of the company.Great · Good · Neutral · At Risk · Poor
- SectorHealthcare
- IndustryBiotechnology
Bachem Holding AG and its subsidiaries supply products for research, clinical development, and commercial use to pharmaceutical and biotech companies worldwide. It develops, produces, and provides regulatory support for peptide active pharmaceutical ingredients, including peptide and oligonucleotide NCEs. The company also offers commercial NCEs and generics, along with project management, quality and regulatory, analytical, GMP production, research-grade production, and supply services. Based in Bubendorf, Switzerland, since 1971, it operates as a subsidiary of Ingro Finanz AG.
Company score
- Sentiment
- 0.47
- SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
- Environment
- -0.13
- EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
- Social
- 0.12
- Governance
- 0.08
- GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
- Sustainability
- 0.01
- SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
- Impact Score
- 0.24
- Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive
Sort by
Order by
Timeframe
No news articles are available for this company yet.
Unable to load company news.
Loading more news
You're all caught up!